William Chou - 10 Oct 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Executive Officer, Director
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
10 Oct 2022
Net transactions value
$0
Form type
4
Filing time
12 Oct 2022, 16:08:09 UTC
Next filing
05 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Employee Stock Option (right to buy) Award $0 +885,000 $0.000000 885,000 10 Oct 2022 Common Stock 885,000 $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on October 10, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.